Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.
5d
The Brighterside of News on MSNMajor discovery identifies the cause of ovarian cancerOvarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.
Researchers have discovered the likely origin of a deadly form of ovarian cancer, offering new hope for early detection and ...
6d
Verywell Health on MSNThe 3 Types of Ovarian Cancer and How They Are DifferentThere are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining characteristics.
Researchers have discovered high-risk cells in fallopian tubes that could lead to high-grade serous ovarian cancer, paving ...
9d
News-Medical.Net on MSNOvarian cancer mutations across populations show similarities and unique differencesAn extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
3d
Clinical Trials Arena on MSNAbbVie reports final analysis from Phase III trial of Elahere for ovarian cancerAbbVie has reported analysis from a Phase III trial that assessed Elahere against chemotherapy for platinum-resistant ovarian ...
AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results